Asia-Pacific promises rapid growth, while increasing tobacco use and investments in oncology centers drive demand for innovative treatments Non-Small Cell Lung Cancer (NSCLC) Market Non-Small Cell ...
Potential breakthrough therapeutic targets $50B+ global immunotherapy market1CHICAGO, March 31, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, ...
New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...
Humanetics Corporation (Humanetics) announced today the launch of a new investigator-initiated clinical trial (IIT) of BIO ...
Setidegrasib exhibited durable clinical activity among pretreated patients with advanced non-small cell lung cancer, ...
Everyday Health on MSN
6 tips to conserve energy and combat fatigue when you have non-small cell lung cancer
Use these six lifestyle habits to conserve energy and fight fatiue during the day.
Researchers reported at the 2026 European Lung Cancer Congress that Hernexeos (zongertinib) led to high response rates and ...
In this video, Lukas Delasos, DO, discusses the accelerated approval of zongertinib as an initial treatment option for adults ...
Sunvozertinib is the first targeted oral treatment for NSCLC with EGFR exon 20 insertion mutations, approved for post-chemotherapy progression cases. The WU-KONG1 Part B study showed a 53.3% objective ...
Combination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it ...
Screening individuals for lung cancer with low-dose CT on a nonrisk basis is associated with a marked reduction in lung cancer mortality and better overall survival, reveals Chinese data.
Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results